Table 1.
Compounds selected for the in vitro inhibition activity assay based on docking or on evidence in the literature.
| Compound Name | Source | Docking Assay |
|---|---|---|
| Nilotinib | Virtual screening | RBD docking |
| Entrectinib | Virtual screening | ACE2 docking |
| Rutin | Virtual screening | ACE2 docking |
| Diosmin | Virtual screening | ACE2 docking |
| Naldemedine | Virtual screening | RBD and ACE2 docking |
| Apilimod | Literature [18] (used as positive control in our validation experiments) |
- |
| Argatroban | Literature [20] | - |
| Otamixaban | Literature [20] | - |
| Ivermectin | Literature [19] | - |